The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pulmonary toxicities in patients (pts) with metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd): The Mayo Clinic Enterprise Experience, updated.
 
Jenna Hoppenworth
Consulting or Advisory Role - AstraZeneca
 
Claire Yee
No Relationships to Disclose
 
Mia Truman
No Relationships to Disclose
 
Jodi Taraba
Consulting or Advisory Role - Academy for Continued Healthcare Learning; AstraZeneca; Lilly; MJH Life Sciences; Novartis; Pharmacy Times; Tersera
Travel, Accommodations, Expenses - MJH Life Sciences
(OPTIONAL) Uncompensated Relationships - Lilly
 
Deanne Smith
No Relationships to Disclose
 
Sarah Premji
No Relationships to Disclose
 
Tanmayi Pai
Honoraria - PracticeLink
Travel, Accommodations, Expenses - ASCO; Florida Society of Clinical Oncology; National Comprehensive Cancer Network; SABCS Store
(OPTIONAL) Uncompensated Relationships - Alexion Pharmaceuticals; Bayer; Foundation Medicine; Guardant Health; Lilly; Lilly; Natera; Seagen
 
Dhauna Karam Prasad
No Relationships to Disclose
 
Farah Raheem
Honoraria - American College of Clinical Pharmacology; BinayTarah Foundation; NCCN; OncLive/MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Lilly
Travel, Accommodations, Expenses - APPOS by CME Horizon; Mayo Clinic
 
Somanshu Sharma
No Relationships to Disclose
 
Drake Alton
No Relationships to Disclose
 
Matthew Goetz
Consulting or Advisory Role - ARC Therapeutics (Inst); ARC Therapeutics (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Atossa Therapeutics (Inst); BeiGene (Inst); bioTheranostics (Inst); BioTheryX; Biovica (Inst); Blueprint Medicines (Inst); Context Therapeutics (Inst); Eagle Pharmaceuticals (Inst); eChinaHealth (Inst); EcoR1 Capital (Inst); Engage Health Media (Inst); Genentech (Inst); Genomic Health (Inst); Genzyme (Inst); Genzyme (Inst); Incyclix Bio (Inst); Intellisphere (Inst); Laekna Therapeutics; Lilly (Inst); Loxo (Inst); Novartis (Inst); Puma Biotechnology (Inst); Rna Diagnostics (Inst); Seagen (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Sermonix Pharmaceuticals (Inst); Tersera
Research Funding - AstraZeneca (Inst); Atossa Genetics (Inst); BioTheryX (Inst); Lilly (Inst); Loxo (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst); SimBioSys (Inst)
Travel, Accommodations, Expenses - Lilly (Inst)
(OPTIONAL) Uncompensated Relationships - Symbios
 
Karthik Giridhar
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo (Inst); Exact Sciences (Inst); Gilead Sciences (Inst); Lilly (Inst); MJH Live Events (Inst); MJH Live Events (Inst); NeoGenomics Laboratories (Inst); Puma Biotechnology (Inst); Tersera (Inst)
Research Funding - Guardant Health (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - GRAIL; QuantumLeap Health
 
Lida Mina
No Relationships to Disclose
 
Roberto Leon-Ferre
Consulting or Advisory Role - AstraZeneca (Inst); Gilead Sciences (Inst); Lyell Immunopharma (Inst); Merck (Inst)